CoChat

p21 Expression in Colon Cancer and Modifying Effects of Patient Age and Body Mass Index on Prognosis

Open access
Ogino, Shuji, Nosho, Katsuhiko, Shima, Kaori, Baba, Yoshifumi, Irahara, Natsumi, Kirkner, Gregory J., Hazra, Aditi, De Vivo, Immaculata, Giovannucci, Edward L., Meyerhardt, Jeffrey A., Fuchs, Charles S. · 2009 · Cancer Epidemiology, Biomarkers & Prevention
Cited by 69

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

p21 (Cyclin-dependent kinase inhibitor-1A, CDKN1A or CIP1) plays a role in regulating cell cycle, and its expression is lost in most colorectal cancers. p21 Is related with energy balance status, cellular senescence, and stem cell aging. Thus, the influence of p21 loss on tumor behavior and clinical outcome may be modified by patient age and body mass index (BMI). Using 647 colon cancers in two independent prospective cohorts, p21 loss was observed in 509 (79%) tumors by immunohistochemistry. Cox proportional hazard models computed hazard ratio (HR) for death, adjusted for potential confounders, including p53, cyclin D1, KRAS, BRAF, PIK3CA, LINE-1 hypomethylation, CpG island methylator phenotype (CIMP), and microsatellite instability (MSI). p21 Loss was independently associated with low colon cancer–specific mortality [HR, 0.58; 95% confidence interval (95% CI), 0.38-0.89; adjusted for the covariates including MSI, CIMP, and LINE-1 methylation]. The prognostic effect of p21 loss differed significantly by age at diagnosis (Pinteraction < 0.0001) and BMI (Pinteraction = 0.002). The adjusted HR for cancer-specific mortality (p21 loss versus p21 expression) was 4.09 (95% CI, 1.13-14.9) among patients <60 year old and 0.37 (95% CI, 0.24-0.59) among patients ≥60 year old. The adverse prognostic effect of obesity was limited to p21-expressing cases (adjusted HR, 5.85; 95% CI, 2.28-15.0; BMI, ≥30 versus <30 kg/m2), but no such effect was observed among p21-lost cases. In conclusion, p21 loss in colon cancer is associated with longer survival among patients ≥60 year old, whereas it is associated with shorter survival among patients <60 year old. Patient BMI also differentially influences prognosis according to p21 CDKN1A status. Our data suggest host-tumor interactions influencing tumor aggressiveness. (Cancer Epidemiol Biomarkers Prev 2009;18(9):2513–21)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-09-0451

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 69

Metadata

Authors
Ogino, S., Nosho, K., Shima, K., Baba, Y., Irahara, N., Kirkner, G. J., Hazra, A., De Vivo, I., Giovannucci, E. L., Meyerhardt, J. A., & Fuchs, C. S.
Venue
Cancer Epidemiology, Biomarkers & Prevention
Published
2009-09-01
Volume
18
Issue
9
Pages
2513-2521
ISSN
  • 1055-9965 (ISSN-L)
  • 1538-7755
OpenAlex
W2120531674
Cited by
69
References
2
FWCI
2.52
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: p21 Expression in Colon Cancer and Modifying Effects of Patient Age and Body Mass Index on Prognosis. https://app.cochat.ai/papers/10.1158/1055-9965.epi-09-0451
The paper
Ogino, S., Nosho, K., Shima, K., Baba, Y., Irahara, N., Kirkner, G. J., Hazra, A., De Vivo, I., Giovannucci, E. L., Meyerhardt, J. A., & Fuchs, C. S. (2009). p21 Expression in Colon Cancer and Modifying Effects of Patient Age and Body Mass Index on Prognosis. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-09-0451

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.